The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Market Cap
3 billion
PE Ratio
-
Beta (volatility)
1.72
Earnings Per Share
-0.34
About
ISIN : US03969K1088
Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical...
Price
Performance Comparison
| Arcutis Biotherapeutics Inc | |
|---|---|
| 1 year return |
+170 %
|
| 5 years return |
+17 %
|
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 18.40 | 0 % |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| 14.98 | -26.88 | 8.90 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
It looks like no dividends is being distributed for this stock...
Number of Outstanding Shares
Financials
Year-over-Year growth
Profitability
Health
News
Earnings report announcement
11/5/2025
CrowdStrike Leads Five Stocks To Watch Near Buy Points
11/15/2025
Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y
11/11/2025
Corcept Q3 Earnings & Revenues Lag Estimates, '25 View Cut, Stock Down
11/5/2025
Biotech Leader Arcutis Is Breaking Out, Up Nearly 36% in 2025
9/29/2025
Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?
9/29/2025
Here are the major earnings after the close Wednesday
8/6/2025
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2025 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.